Pre-trial data showed that TGN1412 was a high-risk compound

摘要

Information submitted to regulators showed that the compound used in the catastrophic Northwick Park trial in March was a high-risk compound unlikely to be suitable for administration to healthy people,a review claims {Lancet 2006;368:1387).